Unseating big pharma: the radical plan for vaccine equity

Amy Maxmen. Nature. 2022 Jul.

. 2022 Jul;607(7918):226-233.

doi: 10.1038/d41586-022-01898-3.

No abstract available

Keywords: Biotechnology; Developing world; Intellectual-property rights; SARS-CoV-2.

Comment in

Why a vaccine hub for low-income countries must succeed.
[No authors listed] [No authors listed] Nature. 2022 Jul;607(7918):211-212. doi: 10.1038/d41586-022-01895-6. Nature. 2022. PMID: 35831593 No abstract available.

1. Levin, A. T. et al. BMJ Glob. Health 7, e008477 (2022). - PubMed - DOI
1. Msowoya, K., Madani, K., Davtalab, R., Mirchi, A. & Lund, J. R. Water Res. Mgmt 30, 5299–5312 (2016). - DOI
1. Drahos, P. & Braithwaite, J. in Balancing Act: Law, Policy and Politics in Globalisation and Global Trade (eds Chen, J. & Walker, G.) 204–223 (Federation Press, 2004).
1. Baker, D., Jayadev, A. & Stiglitz, J. Innovation, Intellectual Property, and Development: A Better Set of Approaches for the 21st Century (AccessIBSA, 2017).
1. Gaviria, M. & Kilic, B. Nature Biotechnol. 39, 546–548 (2021). - PubMed - DOI